Apr 05, 2019 - Top Stock Reports for Boeing, Lockheed Martin & Anthem
Apr 04, 2019 - Novartis' (NVS) generic arm Sandoz resubmits its BLA for the proposed biosimilar of Neulasta.
Mar 29, 2019 - AstraZeneca announces a $6.9 billion cancer deal with Daiichi Sankyo. AbbVie (ABBV), Novartis (NVS) & AstraZeneca's (AZN) drugs get regulatory approvals.
Mar 29, 2019 - Gilead (GILD) and partner Galapagos announce positive results from late-stage studies on investigational drug, filgotinib for the treatment of RA.
Mar 17, 2019 - The big-pharma company could be in much better shape than you think.
Mar 14, 2019 - Roche (RHHBY) gets approval from European Commission for a label expansion of hemophilia drug, Hemlibra.
Mar 13, 2019 - AbbVie, Inc. (NYSE:ABBV) Barclays Global Healthcare Conference March 13, 2019, 10:15 ET Company Participants Robert Michael - SVP & CFO Michael Severino - Vice Chairman & President Conference
Mar 08, 2019 - Roche (RHHBY) obtains approval for the label expansion of Tecentriq in Europe. The company also submits its sNDA for leukemia drug, Venclexta.
Mar 06, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
Mar 04, 2019 - The gene therapy company saw another peer get gobbled up in an acquisition.